HTA154 Comparing Non-Oncological Rare Condition Submissions to the National Institute for Health and Care Excellence (NICE) Versus Scottish Medicines Consortium (SMC) From 2001 to 2021
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1612
https://www.valueinhealthjournal.com/article/S1098-3015(22)03817-7/fulltext
Title :
HTA154 Comparing Non-Oncological Rare Condition Submissions to the National Institute for Health and Care Excellence (NICE) Versus Scottish Medicines Consortium (SMC) From 2001 to 2021
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03817-7&doi=10.1016/j.jval.2022.09.1612
First page :
Section Title :
Open access? :
No
Section Order :
11165